About: Harry Schouten

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Harry Schouten Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) дослідник (uk) onderzoeker (nl)
rdfs:label	Harry Schouten (en) Harry Schouten (nl) Harry Schouten (ast)
skos:prefLabel	Harry Schouten (en) Harry Schouten (nl) Harry Schouten (ast)
name	Harry Schouten (en) Harry Schouten (nl) Harry Schouten (ast)
given name	wds:Q89534570-88DD45DC-B33A-4FDB-8306-4549B2B14F51
given name	Harry
instance of	wds:Q89534570-B9DB19A2-5325-4156-9600-562407E474DB
instance of	Homo sapiens
award received	wds:Q89534570-c184aa2b-413e-cb21-0a06-b309d7a335b6
award received	Officer of the order Orange-Nassau
skos:altLabel	H. Schouten (nl) H.C. Schouten (en) H.C. Schouten (nl) Harry C Schouten (en) prof.dr. H.C. Schouten (en)
occupation	wds:Q89534570-976BF8EF-A425-413B-AF5B-A6A61C1C4F96
employer	wds:Q89534570-0126109C-229E-4852-9AE9-DAD7CABA1C9E
place of birth	wds:Q89534570-3FC2C3D3-E427-4171-BC16-C2FF64F72BAC
sex or gender	wds:Q89534570-2A59A937-0074-4323-8FF5-4A1E570F70D8
ISNI	wds:Q89534570-27a8c54c-4446-502e-740e-b6e9067e1d5c
VIAF ID	wds:Q89534570-cba7867f-b418-4d5d-bfc5-bc02e2404ebd
date of birth	wds:Q89534570-32FC9693-F498-4D8A-B857-4F7179F4412E
family name	wds:Q89534570-B96FDE66-07E3-40A9-9FD1-463A1AC64A9C
VIAF ID	http://viaf.org/viaf/282531113
occupation	university teacher
employer	Maastricht University
place of birth	Roermond
sex or gender	male
ISNI	0000000389180695
VIAF ID	282531113
date of birth	1953-02-11 00:00:00Z (xsd:dateTime)
family name	Schouten
ORCID iD	wds:Q89534570-998A64F5-B865-4AF0-B850-6B2E09A2BD00
ORCID iD	https://orcid.org/0000-0002-2384-4797
ORCID iD	0000-0002-2384-4797
NARCIS researcher ID	wds:Q89534570-2881f540-418a-297c-8588-96e34709b29e
NARCIS researcher ID	PRS1238953
is owl:sameAs of	Harry Schouten
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q89534570
is author of	Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia Salvage second hematopoietic cell transplantation in myeloma Outcome of transplantation for myelofibrosis Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Older patients with myeloma derive similar benefit from autologous transplantation. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature Cytarabine dose for acute myeloid leukemia Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Reg A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Quality of life and non-pain symptoms in patients with cancer. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study Autologous peripheral blood stem cell transplantation for acute myeloid leukemia Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software